Skip to main content
. Author manuscript; available in PMC: 2019 May 10.
Published in final edited form as: ACS Infect Dis. 2018 Dec 19;5(5):759–768. doi: 10.1021/acsinfecdis.8b00269

Table 1.

The structure and antiviral activity of novel HBV nucleocapsid assembly inhibitors

Chemotype Compound Name Structure EC50 (μM) CC50 (μM)
I Comp. 1 graphic file with name nihms-1016903-t0009.jpg 6.68 >10
II Comp. 2 graphic file with name nihms-1016903-t0010.jpg 2.77 >10
III Comp. 3 graphic file with name nihms-1016903-t0011.jpg 0.83 >10
IV Comp. 4 graphic file with name nihms-1016903-t0012.jpg 0.85 >10
Comp. 5 graphic file with name nihms-1016903-t0013.jpg 1.47 >10
V Comp. 6 graphic file with name nihms-1016903-t0014.jpg 2.25 >10
VI Comp. 7 graphic file with name nihms-1016903-t0015.jpg 2.25 >10
VII BA-53038B graphic file with name nihms-1016903-t0016.jpg 3.32 >100

EC50 was determined by dot blot hybridization assay. CC50 was determined by MTT assay.